Loading clinical trials...
Loading clinical trials...
Radiotherapy Combined With Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer (CREATE): A Open-label, Single-arm, Phase II Study
Conditions
Interventions
SBRT
Toripalimab
+1 more
Start Date
June 1, 2022
Primary Completion Date
June 1, 2024
Completion Date
December 1, 2024
Last Updated
May 2, 2022
NCT06681220
NCT01999881
NCT01457469
NCT00528645
NCT00828139
NCT01155258
Lead Sponsor
Wuhan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions